Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices. The SILK average annual return since 2019 is shown above.
The Average Annual Return on the SILK average annual return since 2019 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SILK average annual return since 2019 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SILK average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free SILK Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
